Peer-reviewed veterinary case report
Dog nasal tumor treated with artery chemoembolization to shrink cancer
By Keunho Kim et al.·Published in Frontiers in Veterinary Science·2025·View original on Semantic Scholar →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Case report: Transarterial chemoembolization for nasal hemangiosarcoma in a dog
- Species:
- dog
Plain-English summary
A 10-year-old Welsh Corgi was brought to the vet due to ongoing nasal discharge and changes in the shape of its face. After being diagnosed with a nasal tumor called hemangiosarcoma, the dog initially received radiotherapy and chemotherapy, which only worked for a short time. When the symptoms returned, the vet used a procedure called transarterial chemoembolization (TACE) with a chemotherapy drug to help reduce the tumor size. This treatment successfully eased the dog's symptoms and showed lasting results on follow-up scans, with no major complications noted.
People also search for: dog nasal tumor treatment · Welsh Corgi nasal discharge · hemangiosarcoma in dogs · TACE for dog tumors
Abstract
This report outlines the use of transarterial chemoembolization (TACE) to treat a nasal tumor in a 10-year-old Welsh Corgi. The dog initially presented with persistent nasal discharge and facial deformity, which led to a diagnosis of nasal hemangiosarcoma. Although initial treatments with radiotherapy and chemotherapy provided temporary relief, the symptoms reappeared 11 months later. As a palliative measure, TACE was administered, utilizing carboplatin as the chemotherapeutic agent and gel foam as the embolic material. The procedure successfully reduced the tumor size and alleviated the dog’s symptoms. Follow-up CT scans at 1, 3, 7, and 10 months, demonstrated sustained tumor shrinkage. Interestingly, there was no reperfusion of the embolized vessels, indicating a prolonged therapeutic effect. No significant complications were observed during follow-up. This case highlights the potential of TACE as a palliative option for managing recurrent nasal tumors in dogs, especially when other treatments have limited efficacy. Further research is needed to establish TACE guidelines for treating nasal tumors in veterinary medicine.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Semantic Scholar: https://www.semanticscholar.org/paper/39906045